207 related articles for article (PubMed ID: 32162053)
1. Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
Koka S; Xi L; Kukreja RC
Mol Cell Biochem; 2020 May; 468(1-2):47-58. PubMed ID: 32162053
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice.
Koka S; Das A; Salloum FN; Kukreja RC
Free Radic Biol Med; 2013 Jul; 60():80-8. PubMed ID: 23385031
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice.
Varma A; Das A; Hoke NN; Durrant DE; Salloum FN; Kukreja RC
PLoS One; 2012; 7(9):e45243. PubMed ID: 23028874
[TBL] [Abstract][Full Text] [Related]
4. Long-acting PDE5 inhibitor tadalafil prevents early doxorubicin-induced left ventricle diastolic dysfunction in juvenile mice: potential role of cytoskeletal proteins.
Nagiub M; Filippone S; Durrant D; Das A; Kukreja RC
Can J Physiol Pharmacol; 2017 Mar; 95(3):295-304. PubMed ID: 28238269
[TBL] [Abstract][Full Text] [Related]
5. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide.
Salloum FN; Chau VQ; Hoke NN; Abbate A; Varma A; Ockaili RA; Toldo S; Kukreja RC
Circulation; 2009 Sep; 120(11 Suppl):S31-6. PubMed ID: 19752383
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
Frankenreiter S; Groneberg D; Kuret A; Krieg T; Ruth P; Friebe A; Lukowski R
Cardiovasc Res; 2018 May; 114(6):822-829. PubMed ID: 29438488
[TBL] [Abstract][Full Text] [Related]
8. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.
Koka S; Aluri HS; Xi L; Lesnefsky EJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2014 Jun; 306(11):H1558-68. PubMed ID: 24727492
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts.
Koka S; Xi L; Kukreja RC
Basic Res Cardiol; 2012 Mar; 107(2):249. PubMed ID: 22311732
[TBL] [Abstract][Full Text] [Related]
10. PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.
Wang R; Xi L; Kukreja RC
J Pharmacol Exp Ther; 2017 Apr; 361(1):29-38. PubMed ID: 28123046
[TBL] [Abstract][Full Text] [Related]
11. Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury.
Ahmad N; Wang Y; Ali AK; Ashraf M
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H387-91. PubMed ID: 19429825
[TBL] [Abstract][Full Text] [Related]
12. Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury.
Lux A; Pokreisz P; Swinnen M; Caluwe E; Gillijns H; Szelid Z; Merkely B; Janssens SP
J Pharmacol Exp Ther; 2016 Feb; 356(2):284-92. PubMed ID: 26621143
[TBL] [Abstract][Full Text] [Related]
13. Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
Hiemstra JA; Lee DI; Chakir K; Gutiérrez-Aguilar M; Marshall KD; Zgoda PJ; Cruz Rivera N; Dozier DG; Ferguson BS; Heublein DM; Burnett JC; Scherf C; Ivey JR; Minervini G; McDonald KS; Baines CP; Krenz M; Domeier TL; Emter CA
J Am Heart Assoc; 2016 Apr; 5(4):e003277. PubMed ID: 27098966
[TBL] [Abstract][Full Text] [Related]
14. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
[TBL] [Abstract][Full Text] [Related]
15. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
[TBL] [Abstract][Full Text] [Related]
16. The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size.
Sesti C; Florio V; Johnson EG; Kloner RA
Int J Impot Res; 2007; 19(1):55-61. PubMed ID: 16858368
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.
Tanajak P; Sa-Nguanmoo P; Sivasinprasasn S; Thummasorn S; Siri-Angkul N; Chattipakorn SC; Chattipakorn N
J Endocrinol; 2018 Feb; 236(2):69-84. PubMed ID: 29142025
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
Zhong B; Wang DH
Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
[TBL] [Abstract][Full Text] [Related]
19. Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy.
Bouhidel JO; Wang P; Siu KL; Li H; Youn JY; Cai H
Biochim Biophys Acta; 2015 Feb; 1852(2):277-89. PubMed ID: 24928309
[TBL] [Abstract][Full Text] [Related]
20. Breathing nitric oxide plus hydrogen gas reduces ischemia-reperfusion injury and nitrotyrosine production in murine heart.
Shinbo T; Kokubo K; Sato Y; Hagiri S; Hataishi R; Hirose M; Kobayashi H
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H542-50. PubMed ID: 23771690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
